Skip to Content

Pharmagen Inc PHRX Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 0.00
  • Sector Healthcare
  • Industry Medical Distribution
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  < 0.01
  • Market Cap 517.0760
  • Volume / Avg 1,000.0 /  38,398.4
  • Price / Sales
  • Price / Book
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis PHRX

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics PHRX

Company Profile PHRX

Business Description

Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products. In addition, it also owns and sells a specialized over-the-counter multivitamin product called Clotamin, which is designed for patients suffering from warfarin, a blood thinner that has a known interaction with the vitamin K present in standard over-the-counter multivitamins. Geographically, all the activities are functioned through the region of United States.

9337 Fraser Avenue
Silver Spring, MD, 20910
Industry Medical Distribution
Employees 22

Competitors & Peers PHRX

Morningstar does not cover competitors or peers for this firm.

FAQs for Pharmagen Inc Stock

No. PHRX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

PHRX’s market cap is 517.08.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

PHRX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare PHRX’s historical performance against its industry peers and the overall market.